These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 24874548)

  • 1. Nuclear receptors in neurodegenerative diseases.
    Skerrett R; Malm T; Landreth G
    Neurobiol Dis; 2014 Dec; 72 Pt A():104-16. PubMed ID: 24874548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale.
    Ruffini N; Klingenberg S; Schweiger S; Gerber S
    Cells; 2020 Dec; 9(12):. PubMed ID: 33302607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDL and cognition in neurodegenerative disorders.
    Hottman DA; Chernick D; Cheng S; Wang Z; Li L
    Neurobiol Dis; 2014 Dec; 72 Pt A():22-36. PubMed ID: 25131449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear Receptors as Therapeutic Targets for Neurodegenerative Diseases: Lost in Translation.
    Moutinho M; Codocedo JF; Puntambekar SS; Landreth GE
    Annu Rev Pharmacol Toxicol; 2019 Jan; 59():237-261. PubMed ID: 30208281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P-gp transporter and its role in neurodegenerative diseases.
    Rapposelli S; Digiacomo M; Balsamo A
    Curr Top Med Chem; 2009; 9(2):209-17. PubMed ID: 19200006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial diseases of the brain.
    Chaturvedi RK; Flint Beal M
    Free Radic Biol Med; 2013 Oct; 63():1-29. PubMed ID: 23567191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoid x receptor heterodimers in the metabolic syndrome.
    Shulman AI; Mangelsdorf DJ
    N Engl J Med; 2005 Aug; 353(6):604-15. PubMed ID: 16093469
    [No Abstract]   [Full Text] [Related]  

  • 8. Histone Methylation Regulation in Neurodegenerative Disorders.
    Basavarajappa BS; Subbanna S
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation.
    Zolezzi JM; Santos MJ; Bastías-Candia S; Pinto C; Godoy JA; Inestrosa NC
    Biol Rev Camb Philos Soc; 2017 Nov; 92(4):2046-2069. PubMed ID: 28220655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders.
    Agarwal S; Yadav A; Chaturvedi RK
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1166-1177. PubMed ID: 27514452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LXR agonists: new potential therapeutic drug for neurodegenerative diseases.
    Xu P; Li D; Tang X; Bao X; Huang J; Tang Y; Yang Y; Xu H; Fan X
    Mol Neurobiol; 2013 Dec; 48(3):715-28. PubMed ID: 23625315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondria and neurodegeneration.
    Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
    Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocannabinoids and Neurodegenerative Disorders: Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, and Others.
    Fernández-Ruiz J; Romero J; Ramos JA
    Handb Exp Pharmacol; 2015; 231():233-59. PubMed ID: 26408163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical Exercise-Induced Myokines in Neurodegenerative Diseases.
    Lee B; Shin M; Park Y; Won SY; Cho KS
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering the Role of Aberrant Protein Post-Translational Modification in the Pathology of Neurodegeneration.
    Shafi S; Singh A; Gupta P; Chawla PA; Fayaz F; Sharma A; Pottoo FH
    CNS Neurol Disord Drug Targets; 2021; 20(1):54-67. PubMed ID: 32885763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases.
    Chen D; Zhang T; Lee TH
    Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32784556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations.
    Tan L; Yu JT; Tan L
    J Neurol Sci; 2012 Dec; 323(1-2):1-8. PubMed ID: 22939820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metal-catalyzed disruption of membrane protein and lipid signaling in the pathogenesis of neurodegenerative disorders.
    Mattson MP
    Ann N Y Acad Sci; 2004 Mar; 1012():37-50. PubMed ID: 15105254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of lipid-activated nuclear receptors in shaping macrophage and dendritic cell function: From physiology to pathology.
    Kiss M; Czimmerer Z; Nagy L
    J Allergy Clin Immunol; 2013 Aug; 132(2):264-86. PubMed ID: 23905916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RhoA Signaling in Neurodegenerative Diseases.
    Schmidt SI; Blaabjerg M; Freude K; Meyer M
    Cells; 2022 May; 11(9):. PubMed ID: 35563826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.